ReviewCurrent treatment options in oncology2020

Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations.

Justin A Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.